Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA + IFN-alpha 2a in Recurrent Neuroblastoma or Wilms' Tumor
NCT00001509Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tretinoin, interferon alfa-2a in neuroblastoma, Wilms' tumor, sponsored by National Cancer Institute. Started Jul 1996; status: completed.
02
Drugs
tretinoininterferon alfa-2a
03
Conditions
neuroblastomaWilms' tumor
Beyond the preview
Go deeper on NCT00001509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001509.